International Cancer Imaging Society

International Cancer Imaging Society Meeting and 16th Annual Teaching Course

Cancer Imaging: More Than Meets the Eye

Mon 03 Oct 2016 - Wed 05 Oct 2016

Technology & Innovation Centre (TIC), Glasgow, Scotland, UK

» Meeting details  

» Register here  

Interactive Workshops

Masterclass in Imaging of Prostate Cancer

Mon 24 Oct 2016  Stockholm, Sweden 

» Registration Open 

Masterclass in Imaging of Pancreatic Tumours

Thu 3 Nov 2016  London, UK 

» Registration Open  

Cancer Imaging Journal

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.

 

» President's Message 

» Latest News 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 15% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

How I Read Cancer Imaging Studies: The Master Class Series
20 June 2016

How I Read Cancer Imaging Studies: The Master Class Series

New articles in our masterclass series:

68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report by Isabel Rauscher, Tobias Maurer, Wolfgang P. Fendler, Wieland H. Sommer, Markus Schwaiger and Matthias Eiber.

MRI of endometrium cancer – how we do it by Matthias Meissnitzer and Rosemarie Forstner

» Read more

Great cases and speakers, a superb course. Thank you, good facilities and great food. Friendly faculty.

RM | Dumfries and Galloway, UK

An excellent in depth course, thoroughly recommended.

RM | Cornwall, UK

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.






Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Early indicator of esophageal cancer risk found in Barrett's cells

Published: Tue, 23 Aug 2016 14:00:00 GMT

Testing genetic diversity of Barrett's cells in food pipe could give early indication of which people with Barrett's have higher risk of esophageal cancer.

Gene therapy via ultrasound could offer new tool in fight against heart disease and cancer

Published: Tue, 23 Aug 2016 14:00:00 GMT

Combining ultrasound energy and microbubbles to poke holes in cells may prove to be a new tool in the fight against cardiovascular disease and cancer, according to researchers from the University...

Expecting the worst increases side-effects in breast cancer patients receiving adjuvant hormone therapy

Published: Tue, 23 Aug 2016 14:00:00 GMT

A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side-effects they experienced were...

Breast density and risk may be useful for guiding mammography screening frequency

Published: Tue, 23 Aug 2016 12:00:00 GMT

Women between the ages of 50 and 74 may benefit from more or less frequent mammography screening than is generally recommended, depending on breast density and risk.

Socioeconomic factors - not race or ethnicity - influence survival of younger patients with multiple myeloma

Published: Tue, 23 Aug 2016 12:00:00 GMT

Advances in the treatment of multiple myeloma, a cancer that forms in a type of white blood cell, have led to improved survival predominantly among young and white patients, with less of an...

Asthma: Researchers at University of Liege have discovered a type of eosinophil that plays a protective and beneficial role

Published: Tue, 23 Aug 2016 07:00:00 GMT

With the right treatment schedule, medications known as hypoxia-activated prodrugs (HAPs) could help prevent drug resistance in a subtype of lung cancer, according to a study published in PLOS...

Increased eye cancer risk linked to pigmentation genes that dictate eye color

Published: Mon, 22 Aug 2016 15:00:00 GMT

New research identifies genetic mechanisms behind rare form of melanoma are also associated with genetic risk for skin melanoma.

'Born to be bad' or 'born to be benign' - testing cells for esophageal cancer risk

Published: Mon, 22 Aug 2016 14:00:00 GMT

Genetically analysing lesions in the food pipe could provide an early and accurate test for oesophageal cancer, according to research led by Queen Mary University of London (QMUL), Academic Medical...

Every decade of being overweight ups cancer risk for women

Published: Mon, 22 Aug 2016 13:00:00 GMT

AICR's evidence shows that carrying extra body fat increases risk for 11 types of cancer, including postmenopausal breast and endometrial.

How long does 'chemo brain' last?

Published: Fri, 19 Aug 2016 16:00:00 GMT

Chemo brain refers to a drop in cognitive ability following chemotherapy. A new study sets out to investigate how long this side effect might last.

'Born to be bad' or 'Born to be benign' - Testing cells for oesophageal cancer risk

Published: Fri, 19 Aug 2016 12:00:00 GMT

Genetically analysing lesions in the food pipe could provide an early and accurate test for oesophageal cancer, according to research led by Queen Mary University of London (QMUL), Academic Medical...

Normalizing tumor oxygen supply could be key factor in the fight against cancer

Published: Thu, 18 Aug 2016 07:00:00 GMT

The lack of oxygen in tumor cells changes the cells' gene expression, thereby contributing to the growth of cancer.

Molecule prevents effect of chemotherapy

Published: Wed, 17 Aug 2016 12:00:00 GMT

Danish researchers from Aarhus University Hospital and Aarhus University are behind a possible breakthrough in the treatment of colorectal cancer.

Obesity-related cancer risk increased by overweight duration

Published: Wed, 17 Aug 2016 07:00:00 GMT

A longer duration of overweight and obesity in adulthood is associated with increased risk of several cancers, including breast and endometrial cancers.

Legions of nanorobots target cancerous tumours with precision

Published: Tue, 16 Aug 2016 12:00:00 GMT

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research.

Will you age well? It might depend on your parents' lifespan

Published: Tue, 16 Aug 2016 07:00:00 GMT

Offspring of parents who have a long lifespan are less likely to develop diseases such as heart disease and cancer in older age, a new study finds.

Venetoclax safe, shows promise in patients with acute myelogenous leukemia

Published: Tue, 16 Aug 2016 07:00:00 GMT

Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2...

Cancer overtakes heart disease as the main cause of death in 12 European countries

Published: Mon, 15 Aug 2016 12:00:00 GMT

Although diseases of the heart and blood vessels (cardiovascular disease, CVD) kill more people worldwide than anything else, with 17.

Research reveals insights into genetics behind common blood cancer

Published: Mon, 15 Aug 2016 12:00:00 GMT

Scientists at The Institute of Cancer Research, London, have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps...

Researchers have identified why cancer tumours resist drugs designed to 'starve' tumours

Published: Mon, 15 Aug 2016 09:00:00 GMT

Scientists working at the CNIO institute in Spain have discovered why cancer cells may be resistant to drugs designed to 'starve' tumours of the energy and blood supply which allow them to grow.